# Semarion

**Source:** https://www.startuphub.ai/startups/semarion
**Profile type:** Startup

> A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

## About

Semarion develops SemaCyte® microcarriers, which are ultra-miniaturised, barcoded micro-wells that enable adherent cells to become assay-ready reagents. This technology allows for the multiplexing of cell models in standard liquid handling workflows, facilitating faster, more scalable, and comparable cell-based experiments for in vitro drug discovery. Semarion serves teams looking to generate better data and accelerate drug discovery by removing bottlenecks in adherent cell screening.

## Key facts

- **Slug:** semarion
- **Website:** https://www.semarion.com/
- **Location:** Cambridge, England, United Kingdom
- **Founded:** 2018-01-01
- **Employees:** 12
- **Operating status:** Active
- **Total funding:** $9M
- **Sectors / tags:** Biotechnology, Drug Discovery, Materials Science, Life Sciences, Biotech, MedTech, HealthTech, Advanced Manufacturing & Materials, Microfabrication, Nanomagnetism, Smart Materials, Cell Biology, Assay Development, High-Content Screening
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/semarion/
  - Twitter: https://x.com/Semarion_Ltd

## Frequently asked

### What does Semarion do?

Semarion develops SemaCyte® microcarriers, which are ultra-miniaturised, barcoded micro-wells that enable adherent cells to become assay-ready reagents. This technology allows for the multiplexing of cell models in standard liquid handling workflows, facilitating faster, more scalable, and comparable cell-based experiments for in vitro drug discovery. Semarion serves teams looking to generate better data and accelerate drug discovery by removing bottlenecks in adherent cell screening.

### What is Semarion's revenue?

StartupHub estimates Semarion's annual revenue at $1.7M (range $941K to $4.4M, 68% confidence), based on comparable companies in the sector.

### What is Semarion's valuation?

StartupHub estimates Semarion's effective valuation at $33.5M (range $21.7M to $52.1M, 23% confidence), based on comparable companies in the sector.

### How much funding has Semarion raised?

Semarion has raised a total of $9M in funding. The most recent round on record is Funding Round.

### Where is Semarion headquartered?

Semarion is headquartered in Cambridge, England, United Kingdom.

### When was Semarion founded?

Semarion was founded in 2018.

### What industry does Semarion operate in?

Semarion operates in Biotechnology, Drug Discovery, Materials Science, Life Sciences, Biotech, MedTech.

### How many employees does Semarion have?

Semarion has approximately 12 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Semarion",
          "item": "https://www.startuphub.ai/startups/semarion"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/semarion#webpage",
      "url": "https://www.startuphub.ai/startups/semarion",
      "name": "Semarion - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Semarion. Semarion is a startup founded in 2018, operating in Biotechnology and Drug Discovery. A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology. Headquartered in Cambridge, England, United Kingdom. The company has approximately 12 employees.",
      "dateModified": "2026-05-17T06:00:42.561+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/semarion#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/semarion#organization",
      "name": "Semarion",
      "url": "https://www.semarion.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/93ccde54-0223-4edf-b0ec-93d9e10ab3b3-square.jpg",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/93ccde54-0223-4edf-b0ec-93d9e10ab3b3-square.jpg",
      "description": "This is the official profile of Semarion. Semarion is a startup founded in 2018, operating in Biotechnology and Drug Discovery. A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology. Headquartered in Cambridge, England, United Kingdom. The company has approximately 12 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/semarion/",
        "https://x.com/Semarion_Ltd",
        "https://www.startuphub.ai/startups/semarion"
      ],
      "foundingDate": "2018-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 12
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressRegion": "England",
        "addressCountry": "GB"
      },
      "knowsAbout": [
        "Biotechnology",
        "Drug Discovery",
        "Materials Science",
        "Life Sciences",
        "Biotech",
        "MedTech",
        "HealthTech",
        "Advanced Manufacturing & Materials",
        "Microfabrication",
        "Nanomagnetism",
        "Smart Materials",
        "Cell Biology",
        "Assay Development",
        "High-Content Screening"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/semarion#profile-assessment",
      "name": "Semarion - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/semarion",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/93ccde54-0223-4edf-b0ec-93d9e10ab3b3-square.jpg",
      "category": "Biotechnology",
      "description": "This is the official profile of Semarion. Semarion is a startup founded in 2018, operating in Biotechnology and Drug Discovery. A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology. Headquartered in Cambridge, England, United Kingdom. The company has approximately 12 employees. Agent Readiness score: 42/100. Full audit: https://www.startuphub.ai/startups/semarion/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Semarion"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-17",
        "name": "Semarion - Profile Score 55/100",
        "reviewBody": "This is the official profile of Semarion. Semarion is a startup founded in 2018, operating in Biotechnology and Drug Discovery. A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology. Headquartered in Cambridge, England, United Kingdom. The company has approximately 12 employees. Agent Readiness score: 42/100. Full audit: https://www.startuphub.ai/startups/semarion/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 55,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```